Showing results (1-10 of 186) with videos related to
Sort By:
Pageof 19
Current Gastroenterology Reports|November 7, 2003
Future therapies for inflammatory bowel diseaseStephen J Bickston, Lawrence W Comerford, Fabio CominelliGastroenterology Clinics of North America|June 5, 2004
Treatment of luminal and fistulizing Crohn's disease with infliximabLawrence W Comerford, Stephen J BickstonGastroenterology|February 8, 2002
Intestinal ischemia and peripheral gangrene in a patient with chronic renal failureJesús Rivera-Nieves, Giorgos Bamias, Jonathan Alfert, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 11, 2006
Do patient preferences influence decisions on treatment for patients with steroid-refractory ulcerative colitis?Kristen O Arseneau, Shahnaz Sultan, Dawn T Provenzale, et al.Expert Review of Clinical Immunology|July 3, 2010
Natalizumab for the treatment of Crohn's diseaseStephen J Bickston, Kishor MuniyappaInflammatory Bowel Diseases|November 4, 2020
Financial Toxicity in People With Inflammatory Bowel DiseaseRichard S Bloomfeld, Stephen J BickstonGastroenterology Clinics of North America|November 30, 2006
Infliximab use in luminal Crohn's diseaseJames A Richter, Stephen J BickstonCurrent Treatment Options in Gastroenterology|June 6, 2007
Efficacy of infliximab for luminal and fistulizing Crohn's disease and in ulcerative colitisBrian W Behm, Stephen J BickstonExpert Review of Clinical Immunology|May 19, 2010
Medical management of Crohn's disease: current therapy and recent advancesBrian W Behm, Stephen J BickstonThe Cochrane Database of Systematic Reviews|January 23, 2009
Humanized antibody to the alpha4beta7 integrin for induction of remission in ulcerative colitisBrian W Behm, Stephen J BickstonPageof 19